199 related articles for article (PubMed ID: 5014036)
21. [Clinico-pharmacological studies of a modification of the preparation rosanol to decrease its cost].
Stoianov S; Neshev G; Grŭncharov V
Vutr Boles; 1984; 23(4):28-31. PubMed ID: 6390970
[No Abstract] [Full Text] [Related]
22. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
Cremoncini C; Tominz L
Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
[No Abstract] [Full Text] [Related]
23. [Therapeutic properties of the cholagogue preparation flastapiol in biliary tract diseases in children].
Shmorgun SS; Zinchenko TV; Maksiutina NP
Pediatr Akus Ginekol; 1974; (2):22-4. PubMed ID: 4438009
[No Abstract] [Full Text] [Related]
24. [Amphocholeretic effect of Fumaria officinalis].
Fiegel G
Z Allgemeinmed; 1971 Dec; 47(34):1819-20. PubMed ID: 5134143
[No Abstract] [Full Text] [Related]
25. [Choleretic effect of Bulgarian rose oil].
Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF
Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044
[No Abstract] [Full Text] [Related]
26. [Studies on the potency of action of several choleretics].
Mörsdorf K; Wolf G
Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421
[No Abstract] [Full Text] [Related]
27. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
[TBL] [Abstract][Full Text] [Related]
28. [Clinical observations on the therapeutic activity of the preparation mendiaxon in diseases of the biliary tract].
Ivanov S; Matinheva R; Kostova N
Vutr Boles; 1982; 21(3):17-21. PubMed ID: 7113181
[TBL] [Abstract][Full Text] [Related]
29. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
Marchettini G; Maggi P; Benvenuti C
Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
[No Abstract] [Full Text] [Related]
30. [Clinical experiences with the amphocholereticum Oddibil].
Zawodsky L
Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
[No Abstract] [Full Text] [Related]
31. [Treatment of bile duct diseases. Dyskinesias. Chronic inflammation].
Pontes JF; Tacla M
Arq Gastroenterol; 1981; 18(4):156-61. PubMed ID: 6751300
[TBL] [Abstract][Full Text] [Related]
32. Cholagogues and choleretics.
Hunt T
Practitioner; 1971 Jan; 206(231):51-5. PubMed ID: 5540194
[No Abstract] [Full Text] [Related]
33. [Enteral oxygen therapy in the treatment of chronic diseases of the liver and biliary ducts].
Nezhdanova OV; Vashchenko MA
Vrach Delo; 1968 Jan; 1():120-1. PubMed ID: 5672340
[No Abstract] [Full Text] [Related]
34. [Odeston in treatment of chronic diseases of hepatobiliary system].
Nasonova SV; Lebedeva OI
Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
[No Abstract] [Full Text] [Related]
35. [On the treatment of hepatobiliary diseases with phytopharmaceutics].
Glitsch HW
Hippokrates; 1965 Sep; 36(18):726-9. PubMed ID: 5324310
[No Abstract] [Full Text] [Related]
36. [Pharmacotherapy of chronic cholecystitis].
Tsimmerman IaS
Sov Med; 1987; (4):53-6. PubMed ID: 3603188
[No Abstract] [Full Text] [Related]
37. [Experiences in the conservative treatment of cholecystopathies and cholangiopathies].
Baumgart R
Z Allgemeinmed; 1969 Jul; 45(19):926-7. PubMed ID: 5800266
[No Abstract] [Full Text] [Related]
38. [Therapeutic use of xylith in chronic cholecystitis].
Kulikova ZS
Vrach Delo; 1968 Aug; 8():23-5. PubMed ID: 5741738
[No Abstract] [Full Text] [Related]
39. [Drug therapy of cholelithiasis and cholecystitis].
Kameda H
Naika; 1967 Jun; 19(6):1225-8. PubMed ID: 4865511
[No Abstract] [Full Text] [Related]
40. [Effects of Rheum tanguticum and its extracts on the flow of bile and pancreatic juice in the rat].
Yang YZ; Pei DK; Li SZ
Zhong Xi Yi Jie He Za Zhi; 1987 Mar; 7(3):166-8, 134. PubMed ID: 3607968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
